PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026Frontiers in Oncology0 citationsOpen Access

Machine learning driven LD50 prediction for cancer risk assessment using modern molecular language models

TSTanuj SharmaDrug Discovery Laboratory (Norway)PSPeter SonaDrug Discovery Laboratory (Norway)JJJongsun JungDrug Discovery Laboratory (Norway)

Key Points

Key points are not available for this paper at this time.

Abstract

Introduction Accurate assessment of chemical toxicity is fundamental to cancer research, where early identification of hazardous compounds is critical for prioritizing carcinogenicity testing, therapeutic safety evaluation, and regulatory decision-making. Methods We developed ChemModernBERT, a ModernBERT-based molecular language model pretrained using a curriculum learning strategy on more than 1.8 million SMILES strings to generate chemically informed sequence representations. Using a curated dataset of 8,898 compounds, we systematically compared four molecular representation learning approaches ChemBERT, ChemProp (a directed message passing neural network), ensemble learning, and ChemModernBERT for predicting median lethal dose (LD 50 ) values. Model performance was evaluated using standardized internal and external test sets. Results ChemModernBERT achieved the lowest mean absolute error (MAE) on both internal (0.390) and external (0.393) evaluations and the highest coefficient of determination (R 2 = 0.521 on the external test set), outperforming ChemBERT, ChemProp, and ensemble models under identical experimental conditions. The small generalization gap between internal and external evaluations indicates strong transferability across chemically diverse compounds. Discussion These findings demonstrate that curriculum-pretrained transformer architectures provide a scalable and accurate framework for large-scale toxicity prediction. Such models can support computational pipelines for carcinogenicity assessment, dose selection, and early-stage chemical safety evaluation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sharma et al. (2026) studied this question.

synapsesocial.com/papers/6a11c78081e48c4370dcd438https://doi.org/10.3389/fonc.2026.1788240
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular mechanisms of the preventable causes of cancer in the United States2018 · 157 citations
  2. 2In silico approaches in carcinogenicity hazard assessment: Current status and future needs2021 · 45 citations
  3. 3Can large language models understand molecules?2024 · 48 citations
  4. 4Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing2021 · 1,687 citations
  5. 5Optimizing Diabetes Prediction: Addressing Data Imbalance with Machine Learning Algorithms2024 · 6 citations